Andrew Koren

Sex Differences in the Use of Statins in Community Practice

Michael G. Nanna, Tracy Y. Wang, Qun Xiang et al. · Circulation Cardiovascular Quality and Outcomes · 2019 · 301 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease

Peter P. Tóth, Jamie P. Dwyer, Christopher P. Cannon et al. · Kidney International · 2018 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk

Iris Lin, Jennifer Sung, Robert J. Sanchez et al. · Journal of Managed Care & Specialty Pharmacy · 2016 · 90 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies

Tahir Mahmood, Jessica Minnier, Matthew K. Ito et al. · European Journal of Preventive Cardiology · 2020 · 30 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)

Peter A. McCullough, Christie M. Ballantyne, Santosh K. Sanganalmath et al. · The American Journal of Cardiology · 2018 · 25 citations · Full text

Medicine, Cardiology, Pharmacology +15